Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Prof. Dr. Raphael Borie, APHP, France

Dr. Raphaël Borie, born on August 15, 1977, in Paris, France, is a leading expert in pulmonology and genetic respiratory diseases. Currently a University Professor Hospital Practitioner at Bichat Hospital (Paris Cité University), he has consistently contributed to the advancement of respiratory medicine, particularly in the field of interstitial lung diseases (ILDs). His clinical insight, combined with a strong research portfolio, has positioned him as a prominent figure within the OrphaLung network. A dedicated family man with two children, Dr. Borie is widely respected for his integrity, leadership, and commitment to collaborative medicine. His career reflects a unique blend of academic excellence and impactful translational research, bridging the gap between genomics and clinical care in ILD. He is a registered member of the French Medical Council (Ordre des Médecins No. 75/71138), and his research has influenced European clinical guidelines and improved the understanding of rare genetic pulmonary conditions.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Robust Academic Background:
    Dr. Borie holds a PhD in Genetics, Master’s in Physiology, and HDR (habilitation to supervise doctoral research), which underlines his scientific credibility and ability to lead independent research.

  2. Clinical-Research Integration:
    As a University Professor and Hospital Practitioner, he merges frontline patient care with cutting-edge genetic and respiratory disease research.

  3. High Publication Impact:
    With 283 PubMed-indexed articles and an H-index of 60, Dr. Borie’s work demonstrates strong citation influence, indicating widespread recognition and utility in the scientific community.

  4. International Leadership:
    Active in multinational collaborations (e.g., OrphaLung, ERS), he has co-authored major position statements and clinical trials, influencing European respiratory care guidelines.

  5. Innovation in Rare Diseases:
    A recognized expert in familial interstitial lung disease and telomere disorders, his work has led to earlier diagnosis and targeted therapies—critical in fields where few experts exist.

  6. Recognition and Funding:
    He has secured prestigious mobility grants (ERS, Respirology Teachers College)—a marker of trust in his scientific mission and innovation.

🔍 Areas for Improvement:

  • Wider Public Health Translation: While Dr. Borie’s genomic research is exceptional, expanding into real-world health policy implementation could enhance systemic impact.

  • Patient Engagement & Advocacy: Developing patient-oriented tools or registries (e.g., digital apps or platforms for familial lung diseases) may broaden his outreach beyond academia and clinics.

  • Broader Visibility: Although highly cited in professional circles, participation in international keynote talks, editorial leadership, or mainstream health media could elevate his public and professional visibility.

🎓 Education:

Dr. Borie has pursued an extensive and rigorous academic path focused on respiratory and genetic medicine. He obtained his medical degree with specialization in Allergology and Immunopathology in 2006. A year earlier, in 2005, he earned a Master’s degree in Biology and Physiology of Circulation and Respiration. Demonstrating deep interest in genetics, he completed a PhD in Genetics in 2017, contributing significantly to our understanding of genetic underpinnings in pulmonary fibrosis. In 2019, Dr. Borie achieved the prestigious Habilitation à Diriger des Recherches (HDR) from the University of Paris 7, enabling him to supervise doctoral research. His academic background illustrates a powerful integration of clinical expertise and molecular research—providing him with the tools to lead innovative research projects at the intersection of genomics and pulmonology.

🩺 Experience:

Dr. Raphaël Borie has over 15 years of experience in respiratory medicine. From July 2011 to August 2020, he served as a Hospital Practitioner in the Pneumology Department at Bichat Hospital under Professors Aubier and Crestani. Since September 2020, he has been a University Professor Hospital Practitioner in the same department, affiliated with Paris Cité University. He has contributed to patient care, education of medical students and residents, and cutting-edge research. As part of the OrphaLung network, he plays a critical role in advancing diagnostic tools and treatment approaches for rare lung diseases. He is recognized for his collaborative leadership and interdisciplinary contributions across genetics, immunology, and pulmonology. His international collaborations and authorship of over 280 PubMed-indexed publications demonstrate his ongoing commitment to improving patient outcomes through translational research.

🏆 Awards and Honors:

Dr. Borie’s research excellence has been recognized through several prestigious awards and scholarships. In 2017, he received the European Respiratory Society (ERS) Mobility Grant for his work on Identification of Preclinical Markers of Pulmonary Fibrosis, supporting international collaboration and advanced training. The same year, he was also honored with the Respirology Teachers College Mobility Grant, reinforcing his pioneering research on early detection of fibrotic lung disease. His selection for these awards highlights both scientific innovation and dedication to knowledge exchange. His leadership in multi-center studies and involvement in ERS guideline statements further reflect his status as a thought leader in interstitial lung disease. These honors are a testament to his influence in shaping the future of pulmonary genetics and translational respiratory medicine.

🔬 Research Focus:

Dr. Raphaël Borie’s research centers on familial and genetic interstitial lung diseases, particularly the molecular mechanisms behind pulmonary fibrosis, telomere biology, surfactant-related gene variants, and early detection strategies. He works extensively on identifying genetic risk variants (e.g., MUC5B, DSP) and their implications in idiopathic pulmonary fibrosis. Through his participation in the OrphaLung network, he supports genomic screening for hereditary lung disorders and contributes to developing European guidelines. His work bridges genomic medicine and clinical pulmonology, aiming for earlier diagnosis and personalized treatment approaches. He has led and co-authored critical studies on RTEL1 mutations, telomerase complex defects, and familial ILD phenotypes, helping clinicians globally understand the heterogeneity and systemic implications of genetic lung disorders. His collaborative international research ensures his findings are applied in practice to optimize long-term patient care.

📚Publications Top Notes:

  • 🧬 High risk of lung cancer in surfactant-related gene variant carriers – Eur Respir J, 2024

  • 📄 European Respiratory Society Statement on Familial Pulmonary Fibrosis – Eur Respir J, 2022

  • 🧪 Colocalization of Gene Expression and DNA Methylation with Genetic Risk Variants – Am J Respir Crit Care Med, 2022

  • 🧬 RTEL1 mutations and their phenotypic variability – Eur Respir J, 2019

  • 💊 Safety and efficacy of pirfenidone in telomerase mutation carriers – Eur Respir J, 2018

  • 🌐 Diagnosis and follow-up of familial ILD: International survey – BMC Pulmonary Med, 2025

  • 🧬 New 2023 ACR/EULAR APS criteria performance in young patients – Letter, 2025

  • 🫁 A non-resolving cough: a case of familial pulmonary fibrosis – Breathe, 2025

  • 🧬 PFMG2025: Genomic medicine in French healthcare system – Review, 2025

  • 💊 Efficacy of CFTR modulators in ABCA3-deficiency ILD – Open Access, 2025

  • 🧠 Neurological manifestations in VEXAS syndrome – Journal of Neurology, 2025

  • 💉 Real-life use of PEXIVAS reduced-dose regimen in vasculitis – Ann Rheum Dis, 2025

  • 🧫 Recurrent respiratory papillomatosis with lung involvement – Eur Respir J, 2025

  • 🔍 RA-ILD: genetics to clinical overview – Review, 2025

  • 👶 Childhood ILD survivors in adulthood: European study – Eur Respir J, 2025

🧾 Conclusion:

Dr. Raphaël Borie exemplifies the ideal candidate for the Best Researcher Award. His excellence spans across clinical expertise, academic distinction, and international research leadership, especially in genetic and familial interstitial lung diseases—a field with enormous unmet need. His consistent scholarly output, impactful collaborations, and patient-focused studies highlight a unique blend of depth and innovation. While further expansion into public health frameworks and patient engagement tools would be valuable, his profile already reflects a world-class researcher with transformative contributions to pulmonary medicine.

Yuan Ma | Cell Death Pathway | Best Researcher Award

Posted on by sciencefather

Prof Yuan Ma | Cell Death Pathway | Best Researcher Award

Prof Yuan Ma , Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University , China

Yuan Ma is a prominent Professor in the Department of Respiratory and Critical Care Medicine at The First Affiliated Hospital of Nanjing Medical University, China. With a medical background and a focus on bronchial asthma, Dr. Ma has made significant contributions to understanding the mechanisms of airway inflammation and remodeling. Through extensive research, he aims to identify novel molecular targets for asthma therapies. His work has been recognized internationally, underscoring his dedication to advancing clinical applications in respiratory medicine.

Publication Profile

Scopus

Strengths for the Award

  1. Extensive Research Experience: Yuan Ma has a robust academic background as a Professor in Respiratory and Critical Care Medicine. His focus on airway inflammation and remodeling in asthma is critical, given the increasing prevalence of respiratory diseases.
  2. Publication Record: With 25 articles in domestic journals and 13 in international journals, his publication record demonstrates both local and global recognition of his work. Notable articles in high-impact journals underscore the significance and relevance of his research.
  3. Innovative Contributions: Ma’s identification of necroptosis-related targets in asthma and the discovery of potential therapeutic compounds indicate significant advancements in the understanding and treatment of asthma, contributing to both academic knowledge and clinical practice.
  4. Grant Funding: Successfully presiding over projects funded by the National Natural Science Foundation of China highlights his ability to secure funding for impactful research, a crucial aspect of a successful research career.
  5. Patents: The issuance of 13 patents illustrates his innovative capacity and the potential for practical applications of his research findings.

Areas for Improvement

  1. Broader Collaborations: While Ma has made significant contributions, fostering collaborations with researchers from diverse fields could enhance interdisciplinary insights and expand the impact of his work.
  2. Professional Memberships: Engaging in professional organizations could provide networking opportunities and enhance visibility in the research community, further strengthening his position.
  3. Public Outreach: Increasing public engagement and dissemination of research findings could elevate awareness about asthma and his innovations, potentially leading to broader societal impact.

Education 

Dr. Yuan Ma obtained his medical degree from a prestigious institution, followed by specialized training in respiratory medicine. He completed his PhD with a focus on airway diseases, where he gained insights into the cellular and molecular mechanisms underlying asthma. Throughout his academic journey, Dr. Ma has cultivated a robust foundation in both clinical practice and research methodology, allowing him to bridge the gap between laboratory findings and patient care. His continuous pursuit of knowledge in respiratory health has led him to engage in various professional development opportunities, enhancing his expertise and contributing to his role as a leader in his field.

Experience 

Dr. Yuan Ma has extensive experience in both clinical and research settings, spanning over a decade. He has presided over significant research projects funded by the National Natural Science Foundation of China, exploring the pathogenesis of asthma and potential therapeutic interventions. His impressive track record includes 25 publications in national journals and 13 in international peer-reviewed journals, showcasing his commitment to advancing respiratory medicine. As a professor, he mentors medical students and residents, fostering the next generation of researchers and clinicians. His collaborative work with national and international peers has enriched his research, contributing to innovative approaches in asthma treatment. Additionally, his contributions to patent development demonstrate his drive to translate research findings into practical applications for better patient outcomes.

Research Focus 

Dr. Yuan Ma’s research primarily focuses on the mechanisms of airway inflammation and remodeling in bronchial asthma. He investigates necroptosis-related biomarkers and their regulatory mechanisms, aiming to identify novel therapeutic targets. His work encompasses exploring molecular compounds that can effectively modulate these targets, enhancing asthma diagnosis and treatment options. Dr. Ma’s innovative studies delve into the role of oxidative stress and MAPK signaling pathways in airway smooth muscle cell behavior. By examining the intricate interactions within the airway microenvironment, he seeks to uncover underlying processes that contribute to asthma exacerbations. His research has significant implications for developing targeted therapies, addressing the unmet needs of asthma patients, and ultimately improving clinical outcomes in respiratory medicine.

Publications Top Notes

  1. Screening, identification and targeted intervention of necroptotic biomarkers of asthma. 📄
  2. Caffeic acid phenethyl ester alleviates asthma by regulating the airway microenvironment via the ROS-responsive MAPK/Akt pathway. 🌱
  3. Morin Attenuates Ovalbumin-induced Airway Inflammation by Modulating Oxidative Stress-responsive MAPK Signaling. 🩺
  4. A case of male primary pulmonary choriocarcinoma. 🦠
  5. Implication of dendritic cells in lung diseases: immunological role of Toll-like receptor 4. 🔬
  6. Glomus tumors of the trachea: 2 case reports and a review of the literature. 📚
  7. Diosmetin prevents TGF-β1-induced epithelial-mesenchymal transition via ROS/MAPK signaling pathways. 🧬
  8. SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients. 🦠
  9. Characteristics of H7N9 avian influenza pneumonia: a retrospective analysis of 17 cases. 📊
  10. Galangin attenuates airway remodeling by inhibiting TGF-β1-mediated ROS generation and MAPK/Akt phosphorylation in asthma. 🌿
  11. Melatonin modulates airway smooth muscle cell phenotype by targeting the STAT3/Akt/GSK-3β pathway in experimental asthma. 🌙
  12. Single-agent Maintenance Therapy for Advanced Non-small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-analysis. 🧑‍⚕️
  13. Effect of diosmetin on airway remodeling in a murine model of chronic asthma. 🐭

Conclusion

Yuan Ma’s exceptional research contributions in understanding and treating asthma position him as a strong candidate for the Best Researcher Award. His extensive publication record, innovative findings, and successful grant applications reflect a commitment to advancing respiratory medicine. Addressing areas for improvement could further enhance his profile and influence in the field. Overall, Ma’s achievements warrant recognition, and he is well-suited for this prestigious award.

 

 

Irene Dini | Food Chemistry | Women Researcher Award

Posted on by sciencefather

Prof Irene Dini | Food Chemistry |  Women Researcher Award

Pharmacy Department at  Federico II University of Naples, Italy

Prof. Dini Irene is an esteemed Associate Professor specializing in Food Chemistry at Federico II University of Naples. She holds a Ph.D. in Natural Compounds Pharmacologically Active and is a specialist in Food Science. Prof. Dini has made significant contributions to the field through her extensive research on natural substances, which has resulted in the publication of over 70 papers in indexed journals. She has also authored 8 chapters in international scientific books and 2 chapters for university-level textbooks. Her professional affiliations include serving on the editorial boards of journals such as “E-Journal of Chemistry,” “Antioxidants,” “Molecules,” and “Antibiotics,” all under MDPI. Additionally, she has been a member of the board of directors for CIRANAD, an Interuniversity Centre of Excellence focused on food, nutrition, and the digestive system. Prof. Dini’s dedication to advancing food chemistry and her active involvement in scientific communities underscore her commitment to excellence in research and education.

Profile:

Academic and Professional Background:

Prof. Dini Irene is an esteemed academic with a distinguished career in food chemistry and natural compounds. She holds a Ph.D. in ‘Natural Compounds Pharmacologically Active’ and specializes in ‘Food Science.’ As an Associate Professor in Food Chemistry (CHIM 10) at Federico II University of Naples, Prof. Dini imparts her extensive knowledge to students and advances research in her field.

Leadership and Contributions:

In addition to her academic duties, Prof. Dini has played a significant role in CIRANAD (Interuniversity Centres of Excellence on Food, Nutrition, and Digestive System) as a board member. Her leadership in this interdisciplinary field underscores her commitment to advancing food science and nutrition.

Research Focus: Food Chemistry

Prof. Dini Irene’s research in food chemistry centers on the study and analysis of natural substances with pharmacological activities. Her work aims to explore the chemical composition, properties, and potential health benefits of natural compounds found in various foods. This includes identifying bioactive compounds that can contribute to human health and understanding their mechanisms of action.

Citation Metrics:

  • Total Citations: 2,836
  • Citations Since 2019: 1,762
  • h-index: 30
  • h-index Since 2019: 26
  • i10-index: 52
  • i10-index Since 2019: 47

Publication Top Notes:

  • Antioxidant compound contents and antioxidant activity before and after cooking in sweet and bitter Chenopodium quinoa seeds
    • Published in LWT-Food Science and Technology, 2010
    • Citations: 243
  • Chemical composition, nutritional value and antioxidant properties of Allium caepa L. Var. tropeana (red onion) seeds
    • Published in Food Chemistry, 2008
    • Citations: 148
  • Nutritional and antinutritional composition of Kancolla seeds: an interesting and underexploited Andean food plant
    • Published in Food Chemistry, 2005
    • Citations: 137
  • Studies on the Constituents of Chenopodium quinoa Seeds: Isolation and Characterization of New Triterpene Saponins
    • Published in Journal of Agricultural and Food Chemistry, 2001
    • Citations: 131
  • Saponins in Ipomoea batatas tubers: Isolation, characterization, quantification and antioxidant properties
    • Published in Food Chemistry, 2009
    • Citations: 128
  • The new challenge of green cosmetics: Natural food ingredients for cosmetic formulations
    • Published in Molecules, 2021
    • Citations: 127
  • Phenolic constituents of Kancolla seeds
    • Published in Food Chemistry, 2004
    • Citations: 127
  • Glucosinolates from Maca
    • Published in Biochemical Systematics and Ecology, 2002
    • Citations: 126
  • Effect of industrial and domestic processing on antioxidant properties of pumpkin pulp
    • Published in LWT-Food Science and Technology, 2013
    • Citations: 123
  • Nutricosmetics: A brief overview
    • Published in Phytotherapy Research, 2019
    • Citations: 119

 

yun Shen | Agricultural Economics | Best Researcher Award

Posted on by sciencefather

Prof yun Shen | Agricultural Economics |  Best Researcher Award

Professor at  Sichuan Agricultural University, China

Yun Shen is a distinguished Professor at Sichuan Agricultural University, specializing in applied economics with a focus on rural financial development. With a prolific academic career spanning China and Australia, he has authored over 60 papers in esteemed journals such as “Journal of Rural Studies” and served as a reviewer for “Economic Review”. Yun has led more than 20 research projects, resulting in significant contributions to understanding economic dynamics in rural areas. He has published four books and holds editorial appointments in key journals. Yun’s work includes pioneering the Southwestern Rural Finance and Poverty Alleviation Database and advancing integration theories for urban-rural development. His research impact extends globally, influencing policy and practice.

Profile:

Academic Achievements:

With over 60 papers published in esteemed journals such as “Journal of Rural Studies,” Professor Shen is recognized for his scholarly contributions. He has led numerous national and provincial research projects, garnering over 3000 citations, including several highly cited papers. His work has earned accolades like the Sichuan Provincial Social Science Outstanding Achievement Awards.

Research Focus: Agricultural Economics

Professor Yun Shen, affiliated with Sichuan Agricultural University, specializes in Agricultural Economics. His research delves into the intricate dynamics of rural finance, agricultural development, and natural resource management. With a focus on elucidating the interplay between financial systems, natural resources, and economic growth in rural settings, Professor Shen’s work aims to advance sustainable practices and enhance economic outcomes in agricultural communities.

Citations:

  • Total Citations: 379
  • Citations since 2019: 296
  • h-index: 10
  • i10-index: 10

Publication Top Notes:

  • Index system of sustainable rural development based on the concept of ecological livability
    X Li, H Yang, J Jia, Y Shen, J Liu
    Environmental Impact Assessment Review 86, 106478 (2021)
  • Impacts of livelihood assets on adaptation strategies in response to climate change: Evidence from Pakistan
    GR Sargani, Y Jiang, AA Chandio, Y Shen, Z Ding, A Ali
    Environment, Development and Sustainability 25 (7), 6117-6140 (2023)
  • Construction and empirical analysis of index system for rural revitalization strategy
    J Jia, X Li, Y Shen
    Finance and Economics Science, 70-82 (2018)
  • Analysis of influencing factors of agricultural land use right transfer price – empirical evidence from household and regional levels
    Y Shen, S Zhu, Y Deng, L Teng, R Zhao
    China Rural Observation, 2-17 (2012)
  • Social capital, binary finance, and rural household lending behavior
    Y Shen
    Economic Review, 80-90 (2016)
  • Research on intermediary platform and pricing mechanism in agricultural land transfer market – based on the perspective of bilateral market theory
    S Zhu, Y Shen, CY Shi
    Agricultural Economics and Management, 39-46 (2011)
  • No farmer no food, assessing farmers’ climate change mitigation and adaptation behaviors in farm production
    GR Sargani, Y Jiang, MA Joyo, Y Liu, Y Shen, AA Chandio
    Journal of Rural Studies 100, 103035 (2023)
  • Construction and empirical analysis of evaluation index system for rural industrial revitalization
    Y Shen, H Chen, X Chen, TT Hu
    World Agriculture, 59-69 (2020)
  • Empirical analysis of forest farmers’ cognition of forest reform policy – based on survey of 400 sample households in 10 counties in Jiangxi
    XL Kang, Y Shen, S Zhu
    Journal of Jiangxi Agricultural University: Social Sciences Edition 11 (3), 18-22 (2012)
  • Research on evaluation index system of affluent life of rural residents in China – based on the perspective of building a moderately prosperous society in all respects
    Y Shen, JR Li
    Research World, 42-50 (2020)
  • Chain financing model and precise poverty alleviation effect
    Y Shen, XB Peng
    Economic Research 42, 9 (2016)
  • Analysis of influencing factors of migrant workers’ employment ability
    ZJ Chen, Y Deng, Y Shen
    Journal of Jiangxi Agricultural University: Social Sciences Edition 11 (2), 14-19 (2012)
  • Measurement and spatiotemporal evolution of quality of life of rural residents in China under the perspective of common prosperity
    Y Shen, YX Yin, X Zhong
    Journal of Southwest Minzu University (Humanities and Social Sciences Edition) 43 (2), 103-114 (2022)
  • How do cooperatives alleviate poverty of farmers? Evidence from Rural China
    Y Shen, J Wang, L Wang, B Wu, X Ye, Y Han, R Wang, AA Chandio
    Land 11 (10), 1836 (2022)
  • Urbanization regional spillover and regional economic growth convergence – based on empirical evidence from Chengdu-Chongqing Economic Zone
    Y Shen, YQ Cao, XB Peng
    Journal of Jiangxi University of Finance and Economics, 19-29 (2014)
  • Farm risks, livelihood asset allocation, and adaptation practices in response to climate change: A cross-country analysis
    GR Sargani, Y Shen, Y Liu, MA Joyo, J Liu, Y Jiang, H Zhang
    Frontiers in Environmental Science 10 (2023)
  • Agglomeration of agricultural industry and green development: Efficiency measurement and impact effects
    L Xue, Y Shen, CH Xu
    Economic Compass 37 (3), 45-53 (2020)
  • Agglomeration of agricultural industry and green development: Coupling degree and synergistic effect
    L Xue, CH Xu, Y Shen
    Statistics and Decision, 125-129 (2019)
  • The effects of ecological public welfare jobs on the usage of clean energy by farmers: Evidence from Tibet areas – China
    H Zhang, Y Tang, MA Ankrah Twumasi, AA Chandio, L Guo, R Wan, S Pan, …
    Agriculture 12 (7), 900 (2022)